Racial Disparities in Cardio-Oncology: Contributions of Anti Cancer Therapy Induced Endothelial Dysfunction

被引：0
|
作者：
Birch, Erin
Hader, Shelby
Nishijima, Yoshinori
Toro, Laura Norwood
Terwoord, Janee
机构：
来源：
PHYSIOLOGY | 2024年 / 39卷
关键词：
D O I：
10.1152/physiol.2024.39.S1.2099
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Cardio-Protective Therapy in Cardio-Oncology Quo Vadis?
    Omland, Torbjorn
    CIRCULATION, 2021, 144 (09) : 667 - 669
  • [22] Overcoming LGBTQI plus Disparities in Cardio-Oncology A Call to Action
    Sirufo, Maria Maddalena
    Magnanimi, Lina Maria
    Ginaldi, Lia
    De Martinis, Massimo
    JACC: CARDIOONCOLOGY, 2023, 5 (02): : 267 - 270
  • [23] Cardiac Biomarkers During Cancer Therapy Practical Applications for Cardio-Oncology
    Alvarez-Cardona, Jose A.
    Zhang, Kathleen W.
    Mitchell, Joshua D.
    Zaha, Vlad G.
    Fisch, Michael J.
    Lenihan, Daniel J.
    JACC: CARDIOONCOLOGY, 2020, 2 (05): : 791 - 794
  • [24] Cardio-oncology for better lymphoma therapy outcomes
    Jurczak, Wojciech
    Dlugosz-Danecka, Monika
    Szmit, Sebastian
    LANCET HAEMATOLOGY, 2020, 7 (04): : E273 - E275
  • [25] Deep venous thrombosis and endothelial dysfunction in cancer: prevention and early initiated rehabilitation should be integral to a cardio-oncology programme
    Vrints, Christiaan J. M.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (08) : 1244 - 1247
  • [26] Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy-Related Cardiac Dysfunction
    Mecinaj, Albulena
    Gulati, Geeta
    Ree, Anne Hansen
    Gravdehaug, Berit
    Rosjo, Helge
    Steine, Kjetil
    Wisloff, Torbjorn
    Geisler, Juergen
    Omland, Torbjorn
    Lagethon, Siri
    JACC: CARDIOONCOLOGY, 2024, 6 (01): : 83 - 95
  • [27] Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology
    Albini, Adriana
    Donatelli, Francesco
    Focaccetti, Chiara
    D'Elios, Mario Milco
    Noonan, Douglas M.
    INTERNAL AND EMERGENCY MEDICINE, 2012, 7 (05) : 399 - 401
  • [28] Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology
    Adriana Albini
    Francesco Donatelli
    Chiara Focaccetti
    Mario Milco D’Elios
    Douglas M. Noonan
    Internal and Emergency Medicine, 2012, 7 : 399 - 401
  • [29] The Benefit of Cardio-Oncology Programs for Cancer Patients
    Ismail-Khan, Roohi
    ONCOLOGY-NEW YORK, 2019, 33 (02): : 76 - 76
  • [30] The Impact of the Cancer Moonshot on Cardio-Oncology Science
    Minasian, Lori M.
    Adhikari, Bishow B.
    Dimond, Eileen P.
    Shelburne, Nonniekaye
    Shi, Scarlet
    Desvigne-Nickens, Patrice
    JACC: CARDIOONCOLOGY, 2022, 4 (03): : 413 - 416
12345